Home Page Contact Us Site Map
Home    Articles      Facts      Charity      Lawyers      Directory      Add a Link  &nbs
 
Alimta with cisplatin
The Food and Drug Administration (FDA) approved Alimta (pemetrexed disodium) for ...more
World Trade Center Asbestos
EPA collected wipe samples in a subset of the households that were...more
Diseases Caused By Asbestos Exposure
Pleural plaque is not cancer, and it does not cause cancer...more
Mesothelioma: A Killer Lurks in the Lungs

Mesothelioma & Asbestos News Page

Home Page

 

D. 157 to proceed with school project

CALUMET CITY: Asbestos abatement at Hoover under way.

BY JOAN CARREON
Times Correspondent

This story ran on nwitimes.com on Wednesday, September 29, 2004 12:02 AM CDT

CALUMET CITY -- With contracts and a state construction grant awarded and some work already under way, Hoover-Schrum Elementary District 157 officials are being advised to proceed with plans to renovate and demolish part of the old Hoover Elementary School building.

 Architect Michael Gilfillan advised the School Board on Monday against derailing the Hoover School project.

 His recommendation comes amid talk by some board members about perhaps not proceeding with the Hoover project and instead shifting the focus to Schrum Memorial School, possibly building additional classrooms there.

 The board has already awarded contracts for the Hoover renovation work and the demolition of the east end of the building. Contractors have ordered materials and asbestos abatement work began this week and should be completed in about three weeks, officials say.

 Classes and offices that were housed at Hoover have been temporarily relocated next door, to the newly renovated and expanded former Hoover West School, until the work at Hoover is completed.

 The Hoover project is to include asbestos abatement and the renovation and upgrading of existing early childhood, at-risk kindergarten classrooms, district offices and a School Board meeting room.

 Bob Nielsen, project manager with Henry Bros. Construction, said he anticipates the building will be ready for occupancy in March.

 According to Gilfillan, the district was awarded a $3.2 million Illinois School Construction Grant to help pay for the Hoover West and Hoover work, not for work at Schrum.

  "To do anything but complete the project (at Hoover) would jeopardize your position with the state," he told the board. He estimates  the district also could face the loss of about $350,00 "if you decide to stop this project now."  Instead, the architect suggests the district "continue with the project as initially planned" at Hoover, identify Schrum's space needs, take a look at the district's available financial resources and come up with options for addressing that school's needs, possibly using performance contracting,

 He recommends the district consider moving some walls and "restacking some spaces" at Schrum to accommodate current and future student enrollment.

 

Back to Original Article on Mesothelioma

 

Back to News Page

 

Continue with:

Letter: North project a symptom of a 'Pharaoh complex' Wednesday, September 29, 2004 The design competition is critical as the "New Newton North" process is flawed and failed. Those in charge have lost broken trust with citizens. New Newton North's bizarre agenda is forged in a tightly controlled misinformation process that is prejudiced by the specific objective to build a new school at any cost.

The World Today - Tuesday, 28 September , 2004 12:26:00 Reporter: ELEANOR HALL: Returning to our lead story on the decision by James Hardie's CEO to stand aside but not resign, the NSW Premier Bob Carr has been holding a joint news conference with ACTU leader Greg Combet in Sydney.

Despite investing more than $23 million to convert the former American Thread Co. mills in Windham into a technology center, the state will see the project -- which has created barely one-tenth of the jobs anticipated -- to fall into private hands before the year's end.

UK - Details of a unique, ambitious and decades-long investigation into the causes of breast cancer - The Breakthrough Generations Study - were revealed today by Breakthrough Breast Cancer, the UK's leading breast cancer charity, and The Institute of Cancer Research, one of the world's leading cancer research organisations.

Attention University Students: University policy mandates that under NO circumstances are cockroaches in CV circle to be mercilessly slaughtered for the selfish motives of student comfort. Students of Centennial Village were instructed to let the critters live, as construction under Regan Hall disturbed their natural habitat and thus their migration to CV was the University's fault. In similar news, bug sprays are now considered illegal because "bugs have feelings too, you know."

Chemotherapy May Improve Outcome of Pneumonectomy for Mesothelioma Researchers from Switzerland have reported the outcomes of 19 patients with mesothelioma scheduled to be treated with extrapleural pneumonectomy and radiation therapy after neoadjuvant chemotherapy with Gemzar® (gemcitabine) and Platinol® (cisplatin). The details of this report appeared in the September 1, 2004 issue of the Journal of Clinical Oncology .

Madison County : Where asbestos rules By Paul Hampel Copyright 2004, St. Louis Post-Dispatch 09/18/2004 Madison County 's king of asbestos litigation pushed his way through the crowded courtroom and propped an elbow on the judge's bench.

Greg Combet: Morality will prevail over profit September 27, 2004 NOTHING in my working life has upset me as much as James Hardie's attempt to walk away from people who are suffering disease and death because of exposure to the company's asbestos products. It highlights a disconnection between commercial decisions and morality which is sickening.


General Information About Malignant Mesothelioma
Where can I find Asbestos?
Diagnosing Mesothelioma
Asbestos Information
Damages and Settlements
Medical Procedures
Drugs and Medications
Mesothelioma News
Articles       Facts       Charity       Lawyers       Directory       Add a Link       Clinical Trials       State Coverage